Emalex Biosciences

Emalex Biosciences is owned by Paragon.

Paragon is a company listed under the stock ticker KGaA (DE).

Paragon has a direct presence in 2 countries.

They are in:

Acquisition, funding and merger involving Paragon.

View the org chart displaying its 16 main executives

Create your alert
to follow the executive moves at Emalex Biosciences.

Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
Karius has just announced a $100 Million fundraising (posted on May 3 2024).
Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Contact by email its executives including Eric Messner Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board